| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.2 | 0.0007 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.0009 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |